S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Stock market today: Asian world shares mostly lower after Wall St has its worst week in 6 months
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Oil prices have risen. That's making gas more expensive for US drivers and helping Russia's war
Writers Guild and Hollywood studios reach tentative agreement to end strike. No deal yet for actors
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
AI is on the world's mind. Is the UN the place to figure out what to do about it?
Canadian autoworkers ratify new labor agreement with Ford
This Stock Could Go Up 66% or More. (Ad)
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
The UN's top tech official discusses AI, bringing the world together and what keeps him up at night
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Stock market today: Asian world shares mostly lower after Wall St has its worst week in 6 months
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Oil prices have risen. That's making gas more expensive for US drivers and helping Russia's war
Writers Guild and Hollywood studios reach tentative agreement to end strike. No deal yet for actors
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
AI is on the world's mind. Is the UN the place to figure out what to do about it?
Canadian autoworkers ratify new labor agreement with Ford
This Stock Could Go Up 66% or More. (Ad)
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
The UN's top tech official discusses AI, bringing the world together and what keeps him up at night
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Stock market today: Asian world shares mostly lower after Wall St has its worst week in 6 months
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Oil prices have risen. That's making gas more expensive for US drivers and helping Russia's war
Writers Guild and Hollywood studios reach tentative agreement to end strike. No deal yet for actors
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
AI is on the world's mind. Is the UN the place to figure out what to do about it?
Canadian autoworkers ratify new labor agreement with Ford
This Stock Could Go Up 66% or More. (Ad)
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
The UN's top tech official discusses AI, bringing the world together and what keeps him up at night
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Stock market today: Asian world shares mostly lower after Wall St has its worst week in 6 months
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Oil prices have risen. That's making gas more expensive for US drivers and helping Russia's war
Writers Guild and Hollywood studios reach tentative agreement to end strike. No deal yet for actors
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
AI is on the world's mind. Is the UN the place to figure out what to do about it?
Canadian autoworkers ratify new labor agreement with Ford
This Stock Could Go Up 66% or More. (Ad)
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
The UN's top tech official discusses AI, bringing the world together and what keeps him up at night

Henry Schein (HSIC) Competitors

$73.11
-0.58 (-0.79%)
(As of 09/22/2023 08:52 PM ET)
Compare
Today's Range
$73.01
$73.79
50-Day Range
$73.11
$80.23
52-Week Range
$64.75
$89.72
Volume
564,700 shs
Average Volume
852,308 shs
Market Capitalization
$9.55 billion
P/E Ratio
21.50
Dividend Yield
N/A
Price Target
$84.00

HSIC vs. PDCO, TFX, DVA, QGEN, RGEN, PEN, UTHR, UHS, BIO, and SRPT

Should you be buying Henry Schein stock or one of its competitors? The main competitors of Henry Schein include Patterson Companies (PDCO), Teleflex (TFX), DaVita (DVA), Qiagen (QGEN), Repligen (RGEN), Penumbra (PEN), United Therapeutics (UTHR), Universal Health Services (UHS), Bio-Rad Laboratories (BIO), and Sarepta Therapeutics (SRPT). These companies are all part of the "medical" sector.

Henry Schein vs.

Patterson Companies (NASDAQ:PDCO) and Henry Schein (NASDAQ:HSIC) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, community ranking, dividends, analyst recommendations, profitability and media sentiment.

Henry Schein has higher revenue and earnings than Patterson Companies. Patterson Companies is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Patterson Companies$6.47B0.44$207.56M$2.1913.47
Henry Schein$12.65B0.75$538M$3.4021.50

79.2% of Patterson Companies shares are owned by institutional investors. Comparatively, 93.3% of Henry Schein shares are owned by institutional investors. 1.5% of Patterson Companies shares are owned by insiders. Comparatively, 1.1% of Henry Schein shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Henry Schein received 2 more outperform votes than Patterson Companies when rated by MarketBeat users. However, 52.84% of users gave Patterson Companies an outperform vote while only 51.67% of users gave Henry Schein an outperform vote.

CompanyUnderperformOutperform
Patterson CompaniesOutperform Votes
354
52.84%
Underperform Votes
316
47.16%
Henry ScheinOutperform Votes
356
51.67%
Underperform Votes
333
48.33%

In the previous week, Patterson Companies had 16 more articles in the media than Henry Schein. MarketBeat recorded 20 mentions for Patterson Companies and 4 mentions for Henry Schein. Patterson Companies' average media sentiment score of 1.68 beat Henry Schein's score of -0.01 indicating that Henry Schein is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Patterson Companies
1 Very Positive mention(s)
2 Positive mention(s)
9 Neutral mention(s)
8 Negative mention(s)
0 Very Negative mention(s)
Neutral
Henry Schein
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Patterson Companies presently has a consensus target price of $35.83, indicating a potential upside of 21.43%. Henry Schein has a consensus target price of $84.00, indicating a potential upside of 14.90%. Given Henry Schein's stronger consensus rating and higher probable upside, analysts clearly believe Patterson Companies is more favorable than Henry Schein.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Patterson Companies
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Henry Schein
1 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.29

Patterson Companies has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500.

Henry Schein has a net margin of 3.64% compared to Henry Schein's net margin of 3.28%. Henry Schein's return on equity of 22.24% beat Patterson Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Patterson Companies3.28% 22.24% 8.40%
Henry Schein 3.64%15.76%7.53%

Summary

Henry Schein beats Patterson Companies on 10 of the 18 factors compared between the two stocks.


Get Henry Schein News Delivered to You Automatically

Sign up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSIC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HSIC vs. The Competition

MetricHenry ScheinMedical & hospital equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$9.55B$5.72B$4.33B$6.25B
Dividend YieldN/A2.14%5.81%6.53%
P/E Ratio21.5013.79139.1313.64
Price / Sales0.750.892,911.6854.71
Price / Cash11.3310.2090.04101.36
Price / Book2.422.193.834.78
Net Income$538M$237.43M$121.88M$185.28M
7 Day Performance-1.28%-6.40%110.49%3.51%
1 Month Performance-4.87%-13.65%113.69%8.58%
1 Year Performance8.57%-7.61%129.92%4.85%

Henry Schein Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PDCO
Patterson Companies
2.3963 of 5 stars
$29.05
+2.7%
$35.83
+23.4%
+16.7%$2.78B$6.47B13.267,600
TFX
Teleflex
2.8456 of 5 stars
$209.91
-0.6%
$268.92
+28.1%
-1.7%$9.86B$2.79B26.9515,500
DVA
DaVita
2.0174 of 5 stars
$101.96
+2.2%
$105.29
+3.3%
+14.4%$9.31B$11.61B20.2770,000Positive News
QGEN
Qiagen
2.4607 of 5 stars
$40.11
-1.1%
$49.50
+23.4%
-4.6%$9.25B$1.98B27.296,178
RGEN
Repligen
2.4876 of 5 stars
$165.50
+1.6%
$199.00
+20.2%
-11.4%$9.23B$801.54M68.392,025
PEN
Penumbra
2.5745 of 5 stars
$262.73
+0.2%
$324.38
+23.5%
+33.8%$10.10B$847.13M355.043,900
UTHR
United Therapeutics
3.1388 of 5 stars
$220.67
+1.5%
$296.44
+34.3%
+7.3%$10.36B$1.94B12.48985Insider Selling
UHS
Universal Health Services
2.6471 of 5 stars
$127.81
+0.3%
$151.50
+18.5%
+38.4%$8.87B$13.40B13.2793,800
BIO
Bio-Rad Laboratories
2.5986 of 5 stars
$360.37
-2.0%
$533.00
+47.9%
-16.3%$10.48B$2.80B-24.018,200Analyst Revision
SRPT
Sarepta Therapeutics
2.3024 of 5 stars
$119.11
+0.9%
$173.70
+45.8%
+10.9%$10.48B$933.01M-11.551,162Positive News

Related Companies and Tools

This page (NASDAQ:HSIC) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -